Cargando…
Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients
Proton-pump inhibitors (PPIs) are commonly used after kidney transplantation and there is rarely an incentive to discontinue treatment. In the general population, PPI use has been associated with hypomagnesaemia. We aimed to investigate whether PPI use is associated with plasma magnesium, 24-h urina...
Autores principales: | Douwes, Rianne M., Gomes-Neto, António W., Schutten, Joëlle C., van den Berg, Else, de Borst, Martin H., Berger, Stefan P., Touw, Daan J., Hak, Eelko, Blokzijl, Hans, Navis, Gerjan, Bakker, Stephan J. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947083/ https://www.ncbi.nlm.nih.gov/pubmed/31817776 http://dx.doi.org/10.3390/jcm8122162 |
Ejemplares similares
-
Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019) -
The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study
por: Douwes, Rianne M., et al.
Publicado: (2020) -
Type of proton‐pump inhibitor and risk of iron deficiency in kidney transplant recipients – results from the TransplantLines Biobank and Cohort Study
por: Douwes, Rianne M., et al.
Publicado: (2021) -
Hypomagnesaemia associated with long-term use of proton pump inhibitors
por: Toh, James Wei Tatt, et al.
Publicado: (2015) -
Urinary Oxalate Excretion and Long-Term Outcomes in Kidney Transplant Recipients
por: Tubben, Alwin, et al.
Publicado: (2019)